Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the safety and efficacy of intermittent hypoxia treatment in patients with chronic cerebral hypoperfusion.


Clinical Trial Description

Chronic cerebral hypoperfusion is a common and frequently occurring disease in middle-aged and senior people, and an important cause of multiple diseases such as acute ischemic stroke and vascular dementia. However, current treatments for chronic cerebral hypoperfusion are limited and nonspecific. Intermittent hypoxia refers to periodic intervention with alternating normoxia and hypoxia. Studies have shown that short-term (5-10min), low frequency (3-15 times), and mild to moderate hypoxia (9-16%) usually have protective effects and can improve cerebral blood perfusion. Therefore, this study is an exploratory study combining intermittent hypoxia treatment with chronic cerebral hypoperfusion, aiming to preliminarily explore the safety and potential effectiveness of intermittent hypoxia treatment in the using of chronic cerebral hypoperfusion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05824104
Study type Interventional
Source Capital Medical University
Contact Yuan Wang, M.D.
Phone +86-135 8156 7815
Email wilma0106@163.com
Status Not yet recruiting
Phase N/A
Start date May 10, 2023
Completion date October 10, 2023